Depomed to Present at 28th Annual ROTH Conference

NEWARK, Calif., March 07, 2016 -- Depomed, Inc. (NASDAQ:DEPO) today announced that it will be presenting at the 28^th Annual ROTH Conference in Dana Point, California. The presentation is scheduled for Monday, March 14, 2016 at 10:30 a.m. PDT (1:30 p.m. EDT).

This presentation will be webcast and can be accessed via the Investor Relations page of the Depomed website at www.depomed.com. A recording of the webcast will be archived for 30 days.

About Depomed

Depomed is a leading specialty pharmaceutical company focused on enhancing the lives of the patients, families, physicians, providers and payers we serve through commercializing innovative products for pain and neurology related disorders. Depomed markets six medicines with areas of focus that include mild to severe acute pain, moderate to severe chronic pain, neuropathic pain, migraine and breakthrough cancer pain. Depomed is headquartered in Newark, California. To learn more about Depomed, visit www.depomed.com.

INVESTOR AND MEDIA CONTACT:

Christopher Keenan
VP, Investor Relations and Corporate Communications
510-744-8000